Recovery Is Real, but the Growth Gamble Just Got Riskier

The paradox of Q1 is crisp: Five-Star achieved its highest-ever quarterly disbursement of ₹1,496 Cr, collections surged to 97.9% efficiency with the current book improving 61 basis points quarter-on-quarter, and credit cost fell to 1.85% — all genuine wins that validate the business recovery narrative. And yet reported profit grew only 1.9% YoY, revenue rose just 5.4%, and the AUM growth rate sits at a 4% QoQ pace that, if sustained, would translate to roughly 16% annualized expansion — a full 400 basis points short of the company's stated 20% FY27 guidance. That gap is the story.

Operating expense inflation is eating the gains. Opex stood at 6% of AUM in Q1 — up sharply from the historical 5% baseline — and grew 20–21% year-on-year in absolute terms. This offset the benefit of a 20–21% YoY salary and incentive restructuring tied to the business/collections split, which was supposed to unlock productivity. Credit cost improvement alone should have lifted net interest margin; instead, NIM sat flat, and net profit growth lagged revenue growth. The company has explicitly pushed operating leverage to FY28, guiding for opex of 5.75–6% in FY27 and a steady-state 5.25–5.5% thereafter. In other words: near-term margin compression by design, not accident.

A 4% QoQ AUM expansion is a red flag when guidance is 20% annualized. Management's confidence rests on the assumption that disbursements will sustain at ₹1,500 Cr per quarter, with a 10% seasonal uplift in Q3–Q4, yielding ₹6,500–6,800 Cr annual disbursements and hitting 20% growth. That math is mathematically possible. But it requires repayments to normalize — a reversal of the elevated repayment rates the company has been experiencing as collections efficiency improves. On the call, management acknowledged that repayment rates are currently running 30%, above the normalized 27–28% target. Until those rates drift down, even record disbursements will not compound to 20% AUM growth. Q1's 4% QoQ pace was with ₹1,496 Cr in disbursements. If the math worked as management claims, Q1 should have shown higher AUM growth, not lower.

The market's initial reaction was recovery-positive: the stock popped 0.94% on day 1 post-announcement (with 34.7% delivery), accelerated to +6.23% by day 3, and settled +2.38% by day 5. The move held, suggesting genuine institutional validation of the operational turnaround. However, ownership data tell a different story. FII holding shrank 447 basis points to 48.47% in Q4 FY26 from 52.94% in Q3, while domestic institutions added 285 basis points to 17.58%. That is, foreign money is trimming into the recovery narrative, and domestic dii is the buyer. On valuation: the stock trades at ₹547.95, down 17.7% from its all-time high of ₹666 but up 62% off its 52-week low of ₹338.25. It sits above its 50-day and 200-day simple moving averages (₹501.85 and ₹498, respectively) but just below the 20-day SMA of ₹550.01. RSI at 51.5 is neutral — no overbought signal, but no capitulation either. The technical setup is bullish on paper; the ownership flow is not.